Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 SEK | -4.67% | -10.06% | -64.21% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 109M 1.19B 8.7B |
---|---|---|---|---|---|
Net income 2022 | -76M -829M -6.06B | Net income 2023 | -39M -426M -3.11B | EV / Sales 2022 | - |
Net cash position 2022 | 76.01M 830M 6.06B | Net cash position 2023 | 26.02M 284M 2.08B | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.99
x | P/E ratio 2023 |
-2.78
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.68% |
Latest transcript on Scandion Oncology A/S
1 day | -4.67% | ||
1 week | -10.06% | ||
Current month | -43.03% | ||
1 month | -38.89% | ||
3 months | -63.33% | ||
6 months | +19.37% | ||
Current year | -64.21% |
Managers | Title | Age | Since |
---|---|---|---|
Jan Stenvang
FOU | Founder | - | 31/12/16 |
Chief Executive Officer | 64 | 01/01/23 | |
Johnny Stilou
DFI | Director of Finance/CFO | 57 | 31/07/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 31/03/22 | |
Director/Board Member | 69 | 06/05/18 | |
Martin Møller
CHM | Chairman | 49 | 30/04/21 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 1.43 | -4.67% | 85 665 |
26/04/24 | 1.5 | +3.45% | 37,251 |
25/04/24 | 1.45 | +4.32% | 40,968 |
24/04/24 | 1.39 | -3.81% | 109,713 |
23/04/24 | 1.445 | -9.12% | 93,277 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 11:40 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-64.21% | 5.57M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.64% | 22.15B | |
-17.37% | 21.02B | |
-8.56% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SCOL Stock